Home » House Lawmakers Reintroduce Bill on Medicare to Boost Biosimilars Access
House Lawmakers Reintroduce Bill on Medicare to Boost Biosimilars Access
April 29, 2021
Two members of the House of Representatives, Paul Tonko (D-N.Y.) and Bob Gibbs (R-Ohio), have reintroduced a bill that would require Medicare plans to offer greater access to biosimilars.
The legislation aims to create a mechanism in the Centers for Medicare & Medicaid Services’ Star Ratings Program to assess prescription drug plans based on their ability to provide positive health management and patient outcomes.
“Biosimilars are a safe, effective and cost-saving option,” Tonko said, adding that “unjust, profitable dynamics in America’s healthcare system are blocking access to these alternatives, forcing patients to pay a far higher price for substantially similar medical care.”
Upcoming Events
-
21Oct